As of 4:00pm ET
| +0.08 / +5.00%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 1.20. The median estimate represents a +316.67% increase from the last price of 1.68.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.